Data Foundry

Drug recalls 2020

NP Thyroid 30 — Class I drug recall D-1298-2020

Terminated recall by Acella Pharmaceuticals, LLC, reported 2020-06-10, distributed nationwide. Superpotent Drug.

Recall numberD-1298-2020
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAcella Pharmaceuticals, LLC, Alpharetta, GA, United States
Recall initiated2020-05-22
Classified2020-06-08
Reported by FDA2020-06-10
Terminated2022-01-19
DistributedNationwide (US)
Quantity112,140 bottles
Reason classespotency
NDC42192-0327, 42192-0327-01, 42192-0327-30, 42192-0327-90, 42192-0328, 42192-0328-01, 42192-0328-30, 42192-0328-90, 42192-0329, 42192-0329-01, 42192-0329-10, 42192-0329-30, 42192-0329-90, 42192-0330, 42192-0330-01, 42192-0330-10, 42192-0330-30, 42192-0330-90, 42192-0331, 42192-0331-01, 42192-0331-10, 42192-0331-30, 42192-0331-90
Lot numbersAUG-2020, DEC-2020, JUL-2020, M329A19-1, M329H18-1, M329J18-1, M329J18-2, M329J18-3, M329M18-2, NOV-2020

Product

NP Thyroid 30, Thyroid Tablets, USP, 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-329-01.

Reason for recall

Superpotent Drug.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1298-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.